A Denys
Overview
Explore the profile of A Denys including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
1095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pedersen K, Watt J, Maimone C, Hang H, Denys A, Schroder K, et al.
Alcohol Clin Exp Res (Hoboken)
. 2023 Dec;
47(12):2233-2247.
PMID: 38151780
Background: Excess reactive oxygen species generated by NADPH oxidase 2 (Nox2) in response to ethanol exposure mediate aspects of skeletal toxicity including increased osteoclast differentiation and activity. Because perturbation of...
2.
Denys A, Guiu B, Chevallier P, Digklia A, De Kerviler E, de Baere T
Diagn Interv Imaging
. 2020 May;
101(6):347-353.
PMID: 32360351
The COVID-19 pandemic has deeply impacted the activity of interventional oncology in hospitals and cancer centers. In this review based on official recommendations of different international societies, but also on...
3.
May L, Blatter J, Bize P, Tsoumakidou G, Denys A, Broome M
Br J Oral Maxillofac Surg
. 2019 Nov;
58(1):75-78.
PMID: 31735400
Treatment of bony tumours of the oral and maxillofacial area usually involve resection. However, access to certain areas may be difficult because of the size or site of the tumour....
4.
Marot A, Vieira Barbosa J, Duran R, Deltenre P, Denys A
Diagn Interv Imaging
. 2019 May;
100(6):389.
PMID: 31109822
No abstract available.
5.
Marot A, Barbosa J, Duran R, Deltenre P, Denys A
Diagn Interv Imaging
. 2018 Dec;
100(3):147-156.
PMID: 30503174
Purpose: The purpose of this study was to evaluate the feasibility, safety, and efficacy of portal vein recanalization (PVR) and propose a new classification for better selecting candidates with portal...
6.
Digklia A, Duran R, Homicsko K, Kandalaft L, Hocquelet A, Orcurto A, et al.
Cardiovasc Intervent Radiol
. 2018 Sep;
42(9):1221-1229.
PMID: 30209564
The therapeutic options in the treatment of cancer therapy have been recently significantly increased with systemic immune-targeted therapies. Novel immunotherapy approaches based on immune checkpoint blockade or engineered cytotoxic T...
7.
Hocquelet A, Frulio N, Gallo G, Laurent C, Papadopoulos P, Salut C, et al.
Diagn Interv Imaging
. 2018 Feb;
99(6):371-379.
PMID: 29402629
Purpose: To correlate point-shear wave elastography (SWE) with liver hypertrophy after right portal vein embolization (RPVE) and to determine its usefulness in predicting postoperative liver failure in patients undergoing partial...
8.
Stalder G, Deplanque G, Shabafrouz K, Orcurto A, Bize P, Duran R, et al.
Diagn Interv Imaging
. 2017 Oct;
99(3):179-180.
PMID: 29033238
No abstract available.
9.
Denys A, de Baere T
Diagn Interv Imaging
. 2015 Jun;
96(6):529-30.
PMID: 26068534
No abstract available.
10.
Thiolat A, Denys A, Petit M, Biton J, Lemeiter D, Herve R, et al.
Cytokine
. 2014 Jul;
69(1):87-93.
PMID: 25022966
Interleukin (IL)-35 was initially described as an immunosuppressive cytokine specifically produced by CD4(+)FoxP3(+) regulatory T cells (Treg). Since Treg play a major role in autoimmunity control and protect from inflammation,...